000			02382 a2200757 4500
005			20250517082754.0
264		0	_c20180105
008			201801s 0 0 eng d
022			_a1473-1150
024	7		_a10.1038/tpj.2016.13 _2doi
040			_aNLM _beng _cNLM
100	1		_aGraziano, F
245	0	0	_aGlycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer. _h[electronic resource]
260			_bThe pharmacogenomics journal _c06 2017
300			_a258-264 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study
650	0	4	_aAged
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aColectomy
650	0	4	_aColorectal Neoplasms _xenzymology
650	0	4	_aDisease Progression
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aFemale
650	0	4	_aGene Expression Profiling
650	0	4	_aGene Expression Regulation, Enzymologic
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aGlycolysis _xgenetics
650	0	4	_aHepatectomy
650	0	4	_aHumans
650	0	4	_aItaly
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLiver Neoplasms _xenzymology
650	0	4	_aMale
650	0	4	_aMetastasectomy _xmethods
650	0	4	_aMutation
650	0	4	_aPharmacogenetics
650	0	4	_aPharmacogenomic Variants
650	0	4	_aPhenotype
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aRuzzo, A
700	1		_aGiacomini, E
700	1		_aRicciardi, T
700	1		_aAprile, G
700	1		_aLoupakis, F
700	1		_aLorenzini, P
700	1		_aOngaro, E
700	1		_aZoratto, F
700	1		_aCatalano, V
700	1		_aSarti, D
700	1		_aRulli, E
700	1		_aCremolini, C
700	1		_aDe Nictolis, M
700	1		_aDe Maglio, G
700	1		_aFalcone, A
700	1		_aFiorentini, G
700	1		_aMagnani, M
773	0		_tThe pharmacogenomics journal _gvol. 17 _gno. 3 _gp. 258-264
856	4	0	_uhttps://doi.org/10.1038/tpj.2016.13 _zAvailable from publisher's website
999			_c25781130 _d25781130